Related Experiment Video

Updated: Aug 20, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

86.2K

Use of Asthma Medication During Gestation and Risk of Specific Congenital Anomalies

Ruth P Cusack1, Christiane E Whetstone2, Gail M Gauvreau3

  • 1Department of Medicine, McMaster University, HSC 3U31 F, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.

Immunology and Allergy Clinics of North America
|November 21, 2022
PubMed

Insights

Proper asthma management during pregnancy is crucial for reducing congenital anomalies and improving neonatal outcomes. The benefits of asthma controller and reliever medications outweigh potential risks, emphasizing the need for patient education and therapy compliance.

Area of Science:

  • Obstetrics and Gynecology
  • Pulmonology
  • Neonatology

Background:

  • Poorly controlled asthma during pregnancy poses risks to neonatal outcomes, including congenital anomalies.
  • Concerns exist regarding asthma medication safety in pregnancy, but evidence suggests benefits outweigh risks.

Purpose of the Study:

  • To highlight the importance of appropriate asthma care during pregnancy.
  • To emphasize that the risks of uncontrolled asthma are greater than potential medication risks.

Main Methods:

  • This study is a review of existing literature on asthma management in pregnancy and its impact on neonatal outcomes.
  • Analysis of the risks versus benefits of asthma controller and reliever medications.

Main Results:

  • Appropriate asthma care during pregnancy can significantly reduce the incidence of congenital anomalies.
  • The risk of adverse neonatal outcomes associated with uncontrolled asthma is higher than any potential risks from prescribed asthma medications.

Conclusions:

  • Effective asthma management, including patient education and adherence to therapy, is critical for ensuring positive neonatal outcomes.
  • Healthcare providers should prioritize comprehensive asthma management strategies for pregnant individuals to mitigate risks.

Keywords:
Asthma medicationCongenital anomalyPregnancy

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

11.7K
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

6.9K

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
385
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
343
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
397
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
412